Cours Isodiol International Inc Other OTC
Actions
CA46500L1013
Produits pharmaceutiques
CA 2018 | 19,14 M 17,3 M | CA 2019 | 22,25 M 20,11 M | Capitalisation | 49,96 M 45,15 M |
---|---|---|---|---|---|
Résultat net 2018 | -36 M -32,54 M | Résultat net 2019 | -126 M -114 M | VE / CA 2018 | 12,6 x |
Trésorerie nette 2018 | 15,55 M 14,05 M | Dette nette 2019 | 5,22 M 4,72 M | VE / CA 2019 | 2,48 x |
PER 2018 |
-4,94
x | PER 2019 |
-0,37
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/02/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Director/Board Member | - | 21/11/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+45,15% | 6,34 Md | |
-14,00% | 4,61 Md | |
+9,54% | 3,39 Md | |
-8,99% | 3,29 Md | |
+50,03% | 2,02 Md | |
-6,97% | 1,73 Md | |
-0,31% | 1,67 Md | |
+50,00% | 1,63 Md | |
-10,61% | 1,59 Md |